207 related articles for article (PubMed ID: 24812133)
1. International adaptations of NCCN Clinical Practice Guidelines in Oncology.
Carlson RW; Larsen JK; McClure J; Fitzgerald CL; Venook AP; Benson AB; Anderson BO
J Natl Compr Canc Netw; 2014 May; 12(5):643-8. PubMed ID: 24812133
[TBL] [Abstract][Full Text] [Related]
2. NCCN Framework for Resource Stratification: A Framework for Providing and Improving Global Quality Oncology Care.
Carlson RW; Scavone JL; Koh WJ; McClure JS; Greer BE; Kumar R; McMillian NR; Anderson BO
J Natl Compr Canc Netw; 2016 Aug; 14(8):961-9. PubMed ID: 27496112
[TBL] [Abstract][Full Text] [Related]
3. International adaptation and use of NCCN Guidelines.
Bazarbachi A; Zelenetz AD
J Natl Compr Canc Netw; 2014 May; 12(5 Suppl):838-41. PubMed ID: 24853230
[TBL] [Abstract][Full Text] [Related]
4. The process of NCCN guidelines adaptation to the Middle East and North Africa region.
Jazieh AR; Azim HA; McClure J; Jahanzeb M
J Natl Compr Canc Netw; 2010 Jul; 8 Suppl 3():S5-7. PubMed ID: 20697132
[TBL] [Abstract][Full Text] [Related]
5. What is the Asian Consensus Statement on NCCN clinical practice guidelines in oncology (NCCN-ACS)?
Akaza H
Jpn J Clin Oncol; 2016 Apr; 46(4):299-302. PubMed ID: 26830151
[TBL] [Abstract][Full Text] [Related]
6. Modification and implementation of NCCN guidelines on colon cancer in the Middle East and North Africa region.
Içli F; Akbulut H; Bazarbashi S; Kuzu MA; Mallath MK; Rasul KI; Strong S; Syed AA; Zorlu F; Engstrom PF;
J Natl Compr Canc Netw; 2010 Jul; 8 Suppl 3():S22-5. PubMed ID: 20697127
[TBL] [Abstract][Full Text] [Related]
7. Optimizing the Clinical Utility of Biomarkers in Oncology: The NCCN Biomarkers Compendium.
Birkeland ML; McClure JS
Arch Pathol Lab Med; 2015 May; 139(5):608-11. PubMed ID: 25333835
[TBL] [Abstract][Full Text] [Related]
8. Modification and implementation of NCCN guidelines on breast cancer in the Middle East and North Africa region.
Abulkhair O; Saghir N; Sedky L; Saadedin A; Elzahwary H; Siddiqui N; Al Saleh M; Geara F; Birido N; Al-Eissa N; Al Sukhun S; Abdulkareem H; Ayoub MM; Deirawan F; Fayaz S; Kandil A; Khatib S; El-Mistiri M; Salem D; Sayd el SH; Jaloudi M; Jahanzeb M; Gradishar WI;
J Natl Compr Canc Netw; 2010 Jul; 8 Suppl 3():S8-S15. PubMed ID: 20697133
[TBL] [Abstract][Full Text] [Related]
9. European edition of the NCCN clinical practice guidelines: relevance of the translation and adaptation into Spanish.
Guillem V; Camps C; Carrato A; Díaz-Rubio E; Gascón P
Clin Transl Oncol; 2017 Mar; 19(3):288-290. PubMed ID: 27604422
[TBL] [Abstract][Full Text] [Related]
10. Level of evidence used in recommendations by the National Comprehensive Cancer Network (NCCN) guidelines beyond Food and Drug Administration approvals.
Kurzrock R; Gurski LA; Carlson RW; Ettinger DS; Horwitz SM; Kumar SK; Million L; von Mehren M; Benson AB
Ann Oncol; 2019 Oct; 30(10):1647-1652. PubMed ID: 31373348
[TBL] [Abstract][Full Text] [Related]
11. National Comprehensive Cancer Network Guidelines: Who Makes Them? What Are They? Why Are They Important?
Pluchino LA; D'Amico TA
Ann Thorac Surg; 2020 Dec; 110(6):1789-1795. PubMed ID: 32298647
[TBL] [Abstract][Full Text] [Related]
12. NCCN Frameworks for Resource Stratification of NCCN Guidelines: Adult Cancer Pain and Palliative Care.
Swarm RA; Dans M
J Natl Compr Canc Netw; 2018 May; 16(5S):628-631. PubMed ID: 29784742
[TBL] [Abstract][Full Text] [Related]
13. Modification and implementation of NCCN guidelines on non-small cell lung cancer in the Middle East and North Africa region.
Jazieh AR; Bamefleh H; Demirkazik A; Gaafar RM; Geara FB; Javaid M; Khader J; Khodadad K; Omar W; Saadeddin A; Sabe HA; Shadmehr MB; El Sherif A; Uddin N; Jahanzeb M; Ettinger D;
J Natl Compr Canc Netw; 2010 Jul; 8 Suppl 3():S16-21. PubMed ID: 20697125
[TBL] [Abstract][Full Text] [Related]
14. Modification and implementation of NCCN guidelines on lymphomas in the Middle East and North Africa region.
Bazarbachi A; Azim HA; Alizadeh H; Aljurf M; Barista I; Chaudhri NA; Fahed Z; Fahmy OA; Ghavamzadeh A; Khalaf MH; Khatib S; Kutoubi A; Paydas S; Elayoubi HR; Zaatari G; Zawam HM; Zelenetz AD;
J Natl Compr Canc Netw; 2010 Jul; 8 Suppl 3():S29-35. PubMed ID: 20697129
[TBL] [Abstract][Full Text] [Related]
15. Preliminary report: the development of the NCCN Comparative Therapeutic Index™ as a clinical evaluative process for existing data in oncology.
Li EC; DeMartino J
J Natl Compr Canc Netw; 2010 Aug; 8 Suppl 5():S1-9. PubMed ID: 20870621
[TBL] [Abstract][Full Text] [Related]
16. Discrepancies between ESMO and NCCN breast cancer guidelines: An appraisal.
Zagouri F; Liakou P; Bartsch R; Peccatori FA; Tsigginou A; Dimitrakakis C; Zografos GC; Dimopoulos MA; Azim HA
Breast; 2015 Aug; 24(4):513-23. PubMed ID: 25818651
[TBL] [Abstract][Full Text] [Related]
17. The NCCN guideline program--1998.
Winn RJ; Botnick WZ; Brown NH
Oncology (Williston Park); 1998 Nov; 12(11A):30-4. PubMed ID: 10028501
[TBL] [Abstract][Full Text] [Related]
18. Modification and implementation of NCCN guidelines on prostate cancer in the Middle East and North Africa region.
Hassen WA; Karsan FA; Abbas F; Beduk Y; El-Khodary A; Ghosn M; Khader J; Khauli R; Rabah DM; Shamseddine A; Srinivas S;
J Natl Compr Canc Netw; 2010 Jul; 8 Suppl 3():S26-8. PubMed ID: 20697128
[TBL] [Abstract][Full Text] [Related]
19. Asia Consensus Statement on NCCN Clinical Practice Guideline for bladder cancer.
Nishiyama H
Jpn J Clin Oncol; 2018 Jan; 48(1):3-6. PubMed ID: 29145591
[TBL] [Abstract][Full Text] [Related]
20. Concordance with NCCN Colorectal Cancer Guidelines and ASCO/NCCN Quality Measures: an NCCN institutional analysis.
Romanus D; Weiser MR; Skibber JM; Ter Veer A; Niland JC; Wilson JL; Rajput A; Wong YN; Benson AB; Shibata S; Schrag D
J Natl Compr Canc Netw; 2009 Sep; 7(8):895-904. PubMed ID: 19755049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
